粉样β聚合物在轻度认知障碍患者中激活了外围单细胞
Kristian Juul-Madsen1,2, Peter Parbo3, Rola Ismail4
1Department of Biomedicine, Aarhus University, The Skou Building, Høegh-Guldbergs Gade 10, DK-8000, Aarhus C, Denmark.
Nature communications
|February 9, 2024
概括
从轻度认知障碍患者的血中大量的粉样β聚合物与早期阿尔茨海默病的大脑变化相关. 补充受体4调解了微质体对这些聚合物的吸收,这表明它在粉样蛋白清除中发挥了作用.
科学领域:
- 神经免疫学 神经免疫学
- 神经退行性疾病 神经退行性疾病
- 分子生物学分子生物学
背景情况:
- 周围免疫系统在神经退行性疾病 (如阿尔茨海默氏症) 中的作用很重要,但人们对其了解甚少.
- 阿尔茨海默病往往先于一种特征为轻度认知障碍 (MCI) 的前兆阶段.
研究的目的:
- 调查MCI患者血中粉样β (Aβ) 聚合物的存在和含量.
- 阐明外周免疫细胞与Aβ聚合物相互作用并影响大脑病理学的机制.
主要方法:
- 使用先进成像 (11C-PiB PET,18F-FTP PET) 检测和表征MCI患者的血Aβ聚合物.
- 对单细胞群 (富含CD18) 的分析及其与Aβ聚合物的关联.
- 使用干细胞衍生的微质细胞进行体外研究,以评估补充受体4 (CR4) 在Aβ细胞分裂和 lysosomal活动中的作用.
- 在单细胞中对KIM127整体激活的研究,用于大小选择性Aβ细胞灭菌.
- 水力动力学计算以建模Aβ聚合物与皮层毛细血管的关联.
主要成果:
- 在MCI患者的血中发现了大量的Aβ聚合物 (n=38).
- 血Aβ聚合物与早期阿尔茨海默氏症样脑病理相关,并降低了CD18丰富单细胞的水平.
- 补充受体4被证实是粉样蛋白的高亲缘关系结合剂,调解Aβ聚合细胞和微质中的溶酶体刺激.
- 单细胞整合素激活 (KIM127) 促进了Aβ的大小选择性细胞化.
- Aβ聚合物可能会粘附在皮质毛细血管壁上,可能会将单细胞招募到大脑皮层.
结论:
- 血Aβ聚合物存在于MCI中,并且与早期AD脑病理学有关.
- 补充受体4在Aβ聚合物的微细胞和粉样蛋白平衡中起着至关重要的作用.
- 单细胞向大脑的招募可能受到粘附于大脑血管结构的Aβ聚合物的影响.
相关概念视频
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Alzheimer's Disease: Overview
484
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
484


